A detailed history of Atlantic Union Bankshares Corp transactions in Vigil Neuroscience, Inc. stock. As of the latest transaction made, Atlantic Union Bankshares Corp holds 225 shares of VIGL stock, worth $1,811. This represents 0.0% of its overall portfolio holdings.

Number of Shares
225
Holding current value
$1,811
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 06, 2025

BUY
$1.4 - $7.95 $315 - $1,788
225 New
225 $1,000

Others Institutions Holding VIGL

About Vigil Neuroscience, Inc.


  • Ticker VIGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,268,600
  • Market Cap $228M
  • Description
  • Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases. Its lead product candidate is VGL101, a fully human monoclonal antibody (mAb) that is designed to activate triggering receptor expressed...
More about VIGL
Track This Portfolio

Track Atlantic Union Bankshares Corp Portfolio

Follow Atlantic Union Bankshares Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlantic Union Bankshares Corp, based on Form 13F filings with the SEC.

News

Stay updated on Atlantic Union Bankshares Corp with notifications on news.